Preparation and in vitro characterisation of mucoadhesive polymeric microspheres as intra-nasal delivery systems

被引:43
作者
ElHameed, MDA [1 ]
Kellaway, IW [1 ]
机构
[1] UNIV WALES COLL CARDIFF,WELSH SCH PHARM,CARDIFF CF1 3XF,S GLAM,WALES
关键词
mucoadhesive polymers; microsphere preparation; nasal delivery;
D O I
10.1016/S0939-6411(97)00101-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Microspheres of hydrophilic polymers were prepared by the w/o emulsification solvent evaporation technique with a potential application as drug carriers for nasal administration by insufflation. The microspheres had a median particle size of 38 +/- 1.7 mu m (Carbopol 934P), 38.6 +/- 1.8 mu m (Chitosan), 33.6 +/- 7.2 mu m (HPMC), and 16.5 +/- 4.3 mu m (PVA) prepared using a stirring speed of 2000 rpm for 4 or 4.5 h at 80 degrees C. Chitosan and PVA microspheres were spherical and smooth-surfaced while Carbopol 934P and HPMC were of irregular shape with a rough surface morphology. For Carbopol 934P, the microsphere size was inversely proportional to stirring speed (1200-2000 rpm), and to the percentage of the emulsifier (Arlacel A, 0.2-1% w/w) and proportional to the percentage of core materials (0.2-0.5% w/w). FITC-dextran (Mw 4300 Dal was incorporated into the microspheres with an efficiency of 81 +/- 3.6% (Carbopol 934P), 55 +/- 20% (PVA), 44 +/- 6.7% (HPMC), and 36 +/- 2.7% (Chitosan). The change in initial concentration of FITC, dextran (0-15% w/w) had no effect on the particle size of Carbopol 934P microspheres. The rank order of mucoadhesion for the polymeric microspheres was Carbopol 934P > Chitosan = PVA = HPMC, although Chitosan was > HPMC. The change in content of FITC-dextran showed no significant effect on the mucoadhesive strength of Carbopol 934P microspheres within the concentration range of 0-12% w/w. The FITC-dextran was released from the microspheres initially at a constant rate. However the release rate subsequently decreased over the 24 h test period. No differences were observed for release from Carbopol 934P, PVA and HPMC: all exhibited faster release than that achieved from the Chitosan microspheres which exhibited a size-dependent release effect. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:53 / 60
页数:8
相关论文
共 27 条
[11]   OPTIMIZED FORMULATION OF MAGNETIC CHITOSAN MICROSPHERES CONTAINING THE ANTICANCER AGENT, OXANTRAZOLE [J].
HASSAN, EE ;
PARISH, RC ;
GALLO, JM .
PHARMACEUTICAL RESEARCH, 1992, 9 (03) :390-397
[12]   DIFFUSION RATES AND TRANSPORT PATHWAYS OF FLUORESCEIN ISOTHIOCYANATE (FITC)-LABELED MODEL COMPOUNDS THROUGH BUCCAL EPITHELIUM [J].
HOOGSTRAATE, AJ ;
CULLANDER, C ;
NAGELKERKE, JF ;
SENEL, S ;
VERHOEF, JC ;
JUNGINGER, HE ;
BODDE, HE .
PHARMACEUTICAL RESEARCH, 1994, 11 (01) :83-89
[13]  
HOUNAM RF, 1971, AEROSOL SCI, P2
[14]   THE USE OF ALPHA-AMINOBORONIC ACID-DERIVATIVES TO STABILIZE PEPTIDE DRUGS DURING THEIR INTRANASAL ABSORPTION [J].
HUSSAIN, MA ;
SHENVI, AB ;
ROWE, SM ;
SHEFTER, E .
PHARMACEUTICAL RESEARCH, 1989, 6 (02) :186-189
[15]  
ILLUM L, 1988, INT J PHARM, V46, P261
[16]   BIOADHESIVE MICROSPHERES AS A POTENTIAL NASAL DRUG DELIVERY SYSTEM [J].
ILLUM, L ;
JORGENSEN, H ;
BISGAARD, H ;
KROGSGAARD, O ;
ROSSING, N .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1987, 39 (03) :189-199
[17]  
KIM CK, 1994, INT J PHARM, V106, P213
[18]  
MCMARTIN C, 1987, J PHARM SCI, V76, P534
[19]   MOLECULAR-WEIGHT-DEPENDENT PHARMACOKINETICS OF FLUORESCEIN-LABELED DEXTRANS IN RATS [J].
MEHVAR, R ;
SHEPARD, TL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (09) :908-912
[20]  
MORATH LP, 1995, INT J PHARM, V124, P37